163 results on '"Shokooh S"'
Search Results
2. On The Existence of Solutions to One-Dimensional Fourth-Order Equations
- Author
-
Shokooh, S., Afrouzi, G. A., and Hadjian, A.
- Published
- 2021
- Full Text
- View/download PDF
3. New solution algorithm of coupled nonlinear system of Schrodinger equations
- Author
-
Neirameh, A., Eslami, M., and Shokooh, S.
- Published
- 2018
- Full Text
- View/download PDF
4. Antimicrobial effect of Viola odorata extract with or without zinc oxide nanoparticles on Streptococcus mutans
- Author
-
Maryam Mehrabkhani, Taraneh Movahhed, Hossein Bagheri, Parastoo Tajzadeh, Shokooh Sadat Hamedi, Mahboobe Goli, and Samira Dehghanitafti
- Subjects
tooth decay ,streptococcus mutans ,herbal extract ,zinc oxide ,nanoparticles ,viola odorata ,Dentistry ,RK1-715 - Abstract
Objective: This study aimed to evaluate the antimicrobial efficacy of Viola odorata extract, with or without the addition of zinc oxide nanoparticles (ZnO NPs), against Streptococcus mutans.Methods: Two series of V. odorata hydroalcoholic extracts were prepared at concentrations of 25, 50, 100, and 200 mg/ml. Five hundred ppm ZnO NPs were added to 500 ml of the V. odorata extracts in half of the samples. The antibacterial activity of the extracts was then tested using the agar well diffusion method against S. mutans, and the inhibition zones were determined. The control groups were 0.2% chlorhexidine and Salvadora persica mouthwashes. Statistical analysis was performed using an independent-sample t-test, one-way ANOVA, and Duncan's post-hoc test (α=0.05).Results: Adding ZnO NPs significantly improved the inhibition zone of V. odorata extract at all concentrations (P < 0.05). The largest inhibition zone was observed in the 0.2% chlorhexidine mouthwash, significantly greater than all other groups (P < 0.001). The inhibition diameter for S. persica mouthwash was significantly greater than that of all the V. odorata extracts (P < 0.001), except for the group containing 200 mg/ml extract with ZnO NPs (P > 0.05).Conclusions: Adding 500 ppm ZnO NPs enhanced the antibacterial activity of the V. odorata extract. The antibacterial effect of the 200 mg/ml V. odorata extract combined with ZnO NPs was comparable to that of S. persica mouthwash against S. mutans. Given the anti-inflammatory and antibacterial properties of the V. odorata extract, this formulated mouthwash shows potential for improving patients' oral health.
- Published
- 2024
- Full Text
- View/download PDF
5. Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response
- Author
-
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Pouria Daneii, Aria Hassanpoor, Maedeh Eslami, Zeinab Khazaei Koohpar, Saba Asadi, Abbas Zabihi, Behdokht Jamali, Amin Ghorbani, Noushin Nabavi, Mohammad Reza Memarkashani, Shokooh Salimimoghadam, Afshin Taheriazam, Shing Cheng Tan, Maliheh Entezari, Najma Farahani, and Kiavash Hushmandi
- Subjects
CircRNA ,miRNA ,Cancer therapy ,Chemoresistance ,Non-coding RNA ,Genetics ,QH426-470 - Abstract
The complex interplay of epigenetic factors is essential in regulating the hallmarks of cancer and orchestrating intricate molecular interactions during tumor progression. Circular RNAs (circRNAs), known for their covalently closed loop structures, are non-coding RNA molecules exceptionally resistant to enzymatic degradation, which enhances their stability and regulatory functions in cancer. Similarly, microRNAs (miRNAs) are endogenous non-coding RNAs with linear structures that regulate cellular biological processes akin to circRNAs. Both miRNAs and circRNAs exhibit aberrant expressions in various cancers. Notably, circRNAs can function as sponges for miRNAs, influencing their activity. The circRNA/miRNA interaction plays a pivotal role in the regulation of cancer progression, including in brain, gastrointestinal, gynecological, and urological cancers, influencing key processes such as proliferation, apoptosis, invasion, autophagy, epithelial-mesenchymal transition (EMT), and more. Additionally, this interaction impacts the response of tumor cells to radiotherapy and chemotherapy and contributes to immune evasion, a significant challenge in cancer therapy. Both circRNAs and miRNAs hold potential as biomarkers for cancer prognosis and diagnosis. In this review, we delve into the circRNA-miRNA circuit within human cancers, emphasizing their role in regulating cancer hallmarks and treatment responses. This discussion aims to provide insights for future research to better understand their functions and potentially guide targeted treatments for cancer patients using circRNA/miRNA-based strategies.
- Published
- 2025
- Full Text
- View/download PDF
6. Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications
- Author
-
Kiavash Hushmandi, Daniel J. Klionsky, Amir Reza Aref, Mojtaba Bonyadi, Russel J. Reiter, Noushin Nabavi, Shokooh Salimimoghadam, and Seyed Hassan Saadat
- Subjects
Breast neoplasms ,Endometrial neoplasms ,Ferroptosis ,Noncoding RNAs ,Ovarian neoplasms ,Signal transduction ,Genetics ,QH426-470 - Abstract
Ferroptosis, a recently identified type of non-apoptotic cell death, triggers the elimination of cells in the presence of lipid peroxidation and in an iron-dependent manner. Indeed, ferroptosis-stimulating factors have the ability of suppressing antioxidant capacity, leading to the accumulation of reactive oxygen species (ROS) and the subsequent oxidative death of the cells. Ferroptosis is involved in the pathophysiological basis of different maladies, such as multiple cancers, among which female-oriented malignancies have attracted much attention in recent years. In this context, it has also been unveiled that non-coding RNA transcripts, including microRNAs, long non-coding RNAs, and circular RNAs have regulatory interconnections with the ferroptotic flux, which controls the pathogenic development of diseases. Furthermore, the potential of employing these RNA transcripts as therapeutic targets during the onset of female-specific neoplasms to modulate ferroptosis has become a research hotspot; however, the molecular mechanisms and functional alterations of ferroptosis still require further investigation. The current review comprehensively highlights ferroptosis and its association with non-coding RNAs with a focus on how this crosstalk affects the pathogenesis of female-oriented malignancies, from breast cancer to ovarian, cervical, and endometrial neoplasms, suggesting novel therapeutic targets to decelerate and even block the expansion and development of these tumors.
- Published
- 2024
- Full Text
- View/download PDF
7. Shedding light on function of long non-coding RNAs (lncRNAs) in glioblastoma
- Author
-
Mehrdad Hashemi, Sophie Mousavian Roshanzamir, Sima Orouei, Pouria Daneii, Rasoul Raesi, Haleh Zokaee, Pooria Bikarannejad, Kiana Salmani, Ramin Khorrami, Mahshid Deldar Abad Paskeh, Shokooh Salimimoghadam, Mohsen Rashidi, Kiavash Hushmandi, Afshin Taheriazam, and Maliheh Entezari
- Subjects
LncRNA ,Glioblastoma ,Drug resistance ,Radio-resistance ,Metastasis ,Genetics ,QH426-470 - Abstract
The brain tumors and especially glioblastoma, are affecting life of many people worldwide and due to their high mortality and morbidity, their treatment is of importance and has gained attention in recent years. The abnormal expression of genes is commonly observed in GBM and long non-coding RNAs (lncRNAs) have demonstrated dysregulation in this tumor. LncRNAs have length more than 200 nucleotides and they have been located in cytoplasm and nucleus. The current review focuses on the role of lncRNAs in GBM. There two types of lncRNAs in GBM including tumor-promoting and tumor-suppressor lncRNAs and overexpression of oncogenic lncRNAs increases progression of GBM. LncRNAs can regulate proliferation, cell cycle arrest and metastasis of GBM cells. Wnt, STAT3 and EZH2 are among the molecular pathways affected by lncRNAs in GBM and for regulating metastasis of GBM cells, these RNA molecules mainly affect EMT mechanism. LncRNAs are involved in drug resistance and can induce resistance of GBM cells to temozolomide chemotherapy. Furthermore, lncRNAs stimulate radio-resistance in GBM cells. LncRNAs increase PD-1 expression to mediate immune evasion. LncRNAs can be considered as diagnostic and prognostic tools in GBM and researchers have developed signature from lncRNAs in GBM.
- Published
- 2024
- Full Text
- View/download PDF
8. New exact solutions for Davey–Stewartson system
- Author
-
N. Taghizadeh, Neirameh, A., and Shokooh, S.
- Published
- 2012
- Full Text
- View/download PDF
9. Curcumin in treatment of hematological cancers: Promises and challenges
- Author
-
Maliheh Entezari, Armita Tayari, Mahshid Deldar Abad Paskeh, Simin Khorsand Kheirabad, Sahar Naeemi, Afshin Taheriazam, Hossein Dehghani, Shokooh Salimimoghadam, Mehrdad Hashemi, Sepideh Mirzaei, and Saeed Samarghandian
- Subjects
Curcumin ,Hematological cancers ,Nanoparticles ,Targeted delivery ,Molecular pathway ,Medicine - Abstract
Hematological cancers include leukemia, myeloma and lymphoma and up to 178.000 new cases are diagnosed with these tumors each year. Different kinds of treatment including radiotherapy, chemotherapy, immunotherapy and stem cell transplantation have been employed in the therapy of hematological cancers. However, they are still causing death among patients. On the other hand, curcumin as an anti-cancer agent for the suppression of human cancers has been introduced. The treatment of hematological cancers using curcumin has been followed. Curcumin diminishes viability and survival rate of leukemia, myeloma and lymphoma cells. Curcumin stimulates apoptosis and G2/M arrest to impair progression of tumor. Curcumin decreases levels of matrix metalloproteinases in suppressing cancer metastasis. A number of downstream targets including VEGF, Akt and STAT3 undergo suppression by curcumin in suppressing progression of hematological cancers. Curcumin stimulates DNA damage and reduces resistance of cancer cells to irradiation. Furthermore, curcumin causes drug sensitivity of hematological tumors, especially myeloma. For targeted delivery of curcumin and improving its pharmacokinetic and anti-cancer features, nanostructures containing curcumin and other anti-cancer agents have been developed.
- Published
- 2024
- Full Text
- View/download PDF
10. Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response
- Author
-
Mehrdad Hashemi, Pouria Daneii, Mohammad Arad Zandieh, Rasoul Raesi, Neda Zahmatkesh, Mehrsa Bayat, Anwar Abuelrub, Zeinab Khazaei Koohpar, Amir Reza Aref, Ali Zarrabi, Mohsen Rashidi, Shokooh Salimimoghadam, Maliheh Entezari, Afshin Taheriazam, and Ramin Khorrami
- Subjects
m6A ,Cancer ,miRNA ,lncRNA ,circRNA ,Immune response ,Genetics ,QH426-470 - Abstract
The emergence of RNA modifications has recently been considered as critical post-transcriptional regulations which governed gene expression. N6-methyladenosine (m6A) modification is the most abundant type of RNA modification which is mediated by three distinct classes of proteins called m6A writers, readers, and erasers. Accumulating evidence has been made in understanding the role of m6A modification of non-coding RNAs (ncRNAs) in cancer. Importantly, aberrant expression of ncRNAs and m6A regulators has been elucidated in various cancers. As the key role of ncRNAs in regulation of cancer hallmarks is well accepted now, it could be accepted that m6A modification of ncRNAs could affect cancer progression. The present review intended to discuss the latest knowledge and importance of m6A epigenetic regulation of ncRNAs including mircoRNAs, long non-coding RNAs, and circular RNAs, and their interaction in the context of cancer. Moreover, the current insight into the underlying mechanisms of therapy resistance and also immune response and escape mediated by m6A regulators and ncRNAs are discussed.
- Published
- 2024
- Full Text
- View/download PDF
11. Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies
- Author
-
Mehrdad Hashemi, Mahdi Rezaei, Hadi Rezaeiaghdam, Behdokht Jamali, Zeinab Khazaei Koohpar, Mahsa Tanha, Anahita Bizhanpour, Saba Asadi, Ali Moghadas Jafari, Elaheh Mohandesi Khosroshahi, Maedeh Eslami, Shokooh Salimimoghadam, Noushin Nabavi, Mohsen Rashidi, Eisa Fattah, Afshin Taheriazam, and Maliheh Entezari
- Subjects
Prostate cancer ,Bladder cancer ,Renal cancer ,Wnt ,Chemoresistance ,Nanoparticles ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Cancer is a complex, multistep process characterized by abnormal cell growth and metastasis as well as the capacity of the tumor cells in therapy resistance development. The urological system is particularly susceptible to a group of malignancies known as urological cancers, where an accumulation of genetic alterations drives carcinogenesis. In various human cancers, Wnt singalling is dysregulated; following nuclear transfer of β-catenin, it promotes tumor progression and affects genes expression. Elevated levels of Wnt have been documented in urological cancers, where its overexpression enhances growth and metastasis. Additionally, increased Wnt singalling contributes to chemoresistance in urological cancers, leading to reduced sensitivity to chemotherapy agents like cisplatin, doxorubicin, and paclitaxel. Wnt upregulation can change radiotherapy response of urological cancers. The regulation of Wnt involves various molecular pathways, including Akt, miRNAs, lncRNAs, and circRNAs, all of which play roles in carcinogenesis. Targeting and silencing Wnt or its associated pathways can mitigate tumorigenesis in urological cancers. Anti-cancer compounds such as curcumin and thymoquinone have shown efficacy in suppressing tumorigenesis through the downregulation of Wnt singalling. Notably, nanoparticles have proven effective in treating urological cancers, with several studies in prostate cancer (PCa) using nanoparticles to downregulate Wnt and suppress tumor growth. Future research should focus on developing small molecules that inhibit Wnt singalling to further suppress tumorigenesis and advance the treatment of urological cancers. Moreover, Wnt can be used as reliable biomarker for the diagnosis and prognosis of urological cancers.
- Published
- 2024
- Full Text
- View/download PDF
12. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy
- Author
-
Kiavash Hushmandi, Behzad Einollahi, Seyed Hassan Saadat, E. Hui Clarissa Lee, Marzieh Ramezani Farani, Elena Okina, Yun Suk Huh, Noushin Nabavi, Shokooh Salimimoghadam, and Alan Prem Kumar
- Subjects
SLC ,Amino acid ,Cancer ,Nutrient sensing ,Cancer metabolism ,Internal medicine ,RC31-1245 - Abstract
Background: Solute carrier (SLC) transporters, a diverse family of membrane proteins, are instrumental in orchestrating the intake and efflux of nutrients including amino acids, vitamins, ions, nutrients, etc, across cell membranes. This dynamic process is critical for sustaining the metabolic demands of cancer cells, promoting their survival, proliferation, and adaptation to the tumor microenvironment (TME). Amino acids are fundamental building blocks of cells and play essential roles in protein synthesis, nutrient sensing, and oncogenic signaling pathways. As key transporters of amino acids, SLCs have emerged as crucial players in maintaining cellular amino acid homeostasis, and their dysregulation is implicated in various cancer types. Thus, understanding the intricate connections between amino acids, SLCs, and cancer is pivotal for unraveling novel therapeutic targets and strategies. Scope of Review: In this review, we delve into the significant impact of amino acid carriers of the SLCs family on the growth and progression of cancer and explore the current state of knowledge in this field, shedding light on the molecular mechanisms that underlie these relationships and highlighting potential avenues for future research and clinical interventions. Major Conclusions: Amino acids transportation by SLCs plays a critical role in tumor progression. However, some studies revealed the tumor suppressor function of SLCs. Although several studies evaluated the function of SLC7A11 and SLC1A5, the role of some SLC proteins in cancer is not studied well. To exert their functions, SLCs mediate metabolic rewiring, regulate the maintenance of redox balance, affect main oncogenic pathways, regulate amino acids bioavailability within the TME, and alter the sensitivity of cancer cells to therapeutics. However, different therapeutic methods that prevent the function of SLCs were able to inhibit tumor progression. This comprehensive review provides insights into a rapidly evolving area of cancer biology by focusing on amino acids and their transporters within the SLC superfamily.
- Published
- 2024
- Full Text
- View/download PDF
13. NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies
- Author
-
Aryan Rezaee, Parham Rahmanian, Amirreza Nemati, Farima Sohrabifard, Fatemeh Karimi, Ali Elahinia, Ali Ranjbarpazuki, Rozhin Lashkarbolouki, Sadaf Dezfulian, Mohammad Arad Zandieh, Shokooh Salimimoghadam, Noushin Nabavi, Mohsen Rashidi, Afshin Taheriazam, Mehrdad Hashemi, and Kiavash Hushmandi
- Subjects
Diabetes mellitus ,NF-κB ,Inflammation ,Nephropathy ,Neuropathy ,Cardiomyopathy ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Diabetes mellitus (DM) is a metabolic illness defined by elevated blood glucose levels, mediating various tissue alterations, including the dysfunction of vital organs. Diabetes mellitus (DM) can lead to many consequences that specifically affect the brain, heart, and kidneys. These issues are known as neuropathy, cardiomyopathy, and nephropathy, respectively. Inflammation is acknowledged as a pivotal biological mechanism that contributes to the development of various diabetes consequences. NF-κB modulates inflammation and the immune system at the cellular level. Its abnormal regulation has been identified in several clinical situations, including cancer, inflammatory bowel illnesses, cardiovascular diseases, and Diabetes Mellitus (DM). The purpose of this review is to evaluate the potential impact of NF-κB on complications associated with DM. Enhanced NF-κB activity promotes inflammation, resulting in cellular harm and compromised organ performance. Phytochemicals, which are therapeutic molecules, can potentially decline the NF-κB level, therefore alleviating inflammation and the progression of problems correlated with DM. More importantly, the regulation of NF-κB can be influenced by various factors, such as TLR4 in DM. Highlighting these factors can facilitate the development of novel therapies in the future.
- Published
- 2024
- Full Text
- View/download PDF
14. On the existence of solutions of one-dimensional fourth-order equations
- Author
-
Shokooh, S., primary, Afrouzi, G. A., additional, and Hadjian, A., additional
- Published
- 2020
- Full Text
- View/download PDF
15. A class of fourth-order Kirchhoff type elliptic problems with four solutions
- Author
-
Shokooh, S., primary
- Published
- 2020
- Full Text
- View/download PDF
16. Simultaneous determination of trace amounts of vanadium and molybdenum in water and foodstuff samples using adsorptive cathodic stripping voltammetry
- Author
-
Ensafi, Ali A., Khayamian, Taghi, and Khaloo, Shokooh S.
- Published
- 2008
17. Application of adsorptive cathodic differential pulse stripping method for simultaneous determination of copper and molybdenum using pyrogallol red
- Author
-
Ensafi, Ali A., Khayamian, T., and Khaloo, Shokooh S.
- Published
- 2004
- Full Text
- View/download PDF
18. Quantitative assessment of health, safety, and environment (HSE) resilience based on the Delphi method and analytic hierarchy process (AHP) in municipal solid waste management system: A case study in Tehran
- Author
-
Kamal Karimzadeh, Ghazaleh Monazami Tehrani, Shokooh Sadat Khaloo, Mohammad Hossein Vaziri, Sama Amirkhani Ardeh, and Reza Saeedi
- Subjects
delphi technique ,analytic hierarchy process ,waste management ,perception ,iran ,Environmental sciences ,GE1-350 - Abstract
Background: The health, safety, and environment (HSE) resilience is the ability of a system to adapt, resist and cope with the HSE risks in critical situations. In this study, the HSE resilience in solid waste management (SWM) system of Tehran was quantitatively assessed using HSE resilience index (HSE-RI). Methods: The principles and components of HSE-RI were determined and weighted based on the expert panel opinions using Delphi technique and analytic hierarchy process (AHP). The HSE-RI scores were divided into five categories as very good (80-100), good (65-79), medium (50-64), weak (35-49), and very weak (0-34). Results: The weights of the HSE-RI principles in the SWM system were determined as follows: 0.376 for top management commitment, 0.149 for awareness and risk perception, 0.144 for preparedness, 0.144 for performance, 0.057 for reporting and just culture, 0.0574 for learning culture, 0.055 for flexibility, and 0.017 for redundancy. The highest and lowest scores of the resilience principles in the SWM system were related to the principles of awareness and risk perception (73.6), and reporting and just culture (45.1), respectively. The HSE-RI score in the SWM system was 62.9 (medium). Conclusion: The results of this study based on the Delphi method and AHP showed that the HSE resilience in the SWM system of Tehran was not at the desired level. The principles of top management commitment (with the highest weight), reporting and just culture and preparedness (with the lowest scores) were determined as the most effective points for improving the HSE resilience in the SWM system of Tehran.
- Published
- 2023
- Full Text
- View/download PDF
19. Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy
- Author
-
Mohsen Bagheri, Mohammad Arad Zandieh, Mahshid Daryab, Seyedeh Setareh Samaei, Sarah Gholami, Parham Rahmanian, Sadaf Dezfulian, Mahsa Eary, Aryan Rezaee, Romina Rajabi, Ramin Khorrami, Shokooh Salimimoghadam, Peng Hu, Mohsen Rashidi, Alireza Khodaei Ardakan, Yavuz Nuri Ertas, and Kiavash Hushmandi
- Subjects
Oxaliplatin ,Targeted delivery ,Chemoresistance ,Synergistic cancer therapy ,Gene and drug delivery ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
As a clinically approved treatment strategy, chemotherapy-mediated tumor suppression has been compromised, and in spite of introducing various kinds of anticancer drugs, cancer eradication with chemotherapy is still impossible. Chemotherapy drugs have been beneficial in improving the prognosis of cancer patients, but after resistance emerged, their potential disappeared. Oxaliplatin (OXA) efficacy in tumor suppression has been compromised by resistance. Due to the dysregulation of pathways and mechanisms in OXA resistance, it is suggested to develop novel strategies for overcoming drug resistance. The targeted delivery of OXA by nanostructures is described here. The targeted delivery of OXA in cancer can be mediated by polymeric, metal, lipid and carbon nanostructures. The advantageous of these nanocarriers is that they enhance the accumulation of OXA in tumor and promote its cytotoxicity. Moreover, (nano)platforms mediate the co-delivery of OXA with drugs and genes in synergistic cancer therapy, overcoming OXA resistance and improving insights in cancer patient treatment in the future. Moreover, smart nanostructures, including pH-, redox-, light-, and thermo-sensitive nanostructures, have been designed for OXA delivery and cancer therapy. The application of nanoparticle-mediated phototherapy can increase OXA's potential in cancer suppression. All of these subjects and their clinical implications are discussed in the current review.
- Published
- 2024
- Full Text
- View/download PDF
20. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery
- Author
-
Mehrdad Hashemi, Rezvaneh Aparviz, Marzie Beickzade, Mahshid Deldar Abad Paskeh, Simin Khorsand Kheirabad, Zeinab Khazaei Koohpar, Amir Moravej, Hossein Dehghani, Hamidreza Saebfar, Mohammad Arad Zandieh, Shokooh Salimimoghadam, Mohsen Rashidi, Afshin Taheriazam, Maliheh Entezari, and Saeed Samarghandian
- Subjects
Gastric cancer ,SiRNA ,Nanoparticles ,Gene delivery ,Cancer therapy ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Gastric cancer poses a significant health challenge, and exploring innovative therapeutic strategies is imperative. RNA interference (RNAi) has employed as an important therapeutic strategy for diseases by selectively targeting key pathways involved in diseases pathogenesis. Small interfering RNA (siRNA), a potent RNAi tool, possesses the capability to silence genes and downregulate their expression. This review provides a comprehensive examination of the potential applications of small interfering RNA (siRNA) and short hairpin RNA (shRNA), supplemented by an in-depth analysis of nanoscale delivery systems, in the context of gastric cancer treatment. The potential of siRNA to markedly diminish the proliferation and invasion of gastric cancer cells through the modulation of critical molecular pathways, including PI3K, Akt, and EMT, is highlighted. Besides, siRNA demonstrates its efficacy in inducing chemosensitivity in gastric tumor cells, thus impeding tumor progression. However, the translational potential of unmodified siRNA faces challenges, particularly in vivo and during clinical trials. To address this, we underscore the pivotal role of nanostructures in facilitating the delivery of siRNA to gastric cancer cells, effectively suppressing their progression and enhancing gene silencing efficiency. These siRNA-loaded nanoparticles exhibit robust internalization into gastric cancer cells, showcasing their potential to significantly reduce tumor progression. The translation of these findings into clinical trials holds promise for advancing the treatment of gastric cancer patients.
- Published
- 2023
- Full Text
- View/download PDF
21. Cobalt(II) salophen-modified carbon-paste electrode for potentiometric and voltammetric determination of cysteine
- Author
-
Amini, Mohammad K., Khorasani, Jafar H., Khaloo, Shokooh S., and Tangestaninejad, Shahram
- Published
- 2003
- Full Text
- View/download PDF
22. Semi-quantitative health risk assessment of exposure to chemicals in an aluminum rolling mill.
- Author
-
Sanjari, Ashraf, Saeedi, Reza, and Khaloo, Shokooh S.
- Subjects
HEALTH risk assessment ,RISK exposure ,OCCUPATIONAL exposure ,ALUMINUM ,ROLLING-mills ,ALUMINUM industry ,ROLLS (Rolling-mills) - Abstract
The main goal of this study was to evaluate the health risks resulting from occupational exposure to chemicals in an aluminum rolling mill to propose effective control measures. Exposure of workers to chemicals was assessed based on the Singapore Health Department's methodology. The health risks of exposure to the identified chemicals and the relative risk of developing cancer due to exposure to benzene were assessed. According to the results, the risk level of exposure to sulfuric acid in the washing line and to manganese in the manufacturing unit were high. In assessing the risk of developing cancer arising from benzene exposure, the lifetime cancer risk was found in the range 10
−4 –10−6 (the possible range). The results indicated that in the aluminum rolling industry, occupational exposure to 75% of the chemicals had a low risk level, 15% had a moderate risk level and 10% had a high risk level. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
23. Semi-quantitative health risk assessment of exposure to chemicals in an aluminum rolling mill
- Author
-
Sanjari, Ashraf, primary, Saeedi, Reza, additional, and Khaloo, Shokooh S., additional
- Published
- 2019
- Full Text
- View/download PDF
24. Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
- Author
-
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, Maliheh Entezari, Mahsa Mojtabavi, Behnaz Raei, Mohammad Arad Zandieh, Mitra Behroozaghdam, Sepideh Mirzaei, Kiavash Hushmandi, Noushin Nabavi, Shokooh Salimimoghadam, Jun Ren, Mohsen Rashidi, Rasoul Raesi, Afshin Taheriazam, Athanasios Alexiou, Marios Papadakis, and Shing Cheng Tan
- Subjects
Hepatocellular carcinoma ,Liver cancer ,Noncoding transcripts ,STAT3 ,Molecular signaling ,Cytology ,QH573-671 - Abstract
Abstract Hepatocellular carcinoma (HCC) is considered one of the greatest challenges to human life and is the most common form of liver cancer. Treatment of HCC depends on chemotherapy, radiotherapy, surgery, and immunotherapy, all of which have their own drawbacks, and patients may develop resistance to these therapies due to the aggressive behavior of HCC cells. New and effective therapies for HCC can be developed by targeting molecular signaling pathways. The expression of signal transducer and activator of transcription 3 (STAT3) in human cancer cells changes, and during cancer progression, the expression tends to increase. After induction of STAT3 signaling by growth factors and cytokines, STAT3 is phosphorylated and translocated to the nucleus to regulate cancer progression. The concept of the current review revolves around the expression and phosphorylation status of STAT3 in HCC, and studies show that the expression of STAT3 is high during the progression of HCC. This review addresses the function of STAT3 as an oncogenic factor in HCC, as STAT3 is able to prevent apoptosis and thus promote the progression of HCC. Moreover, STAT3 regulates both survival- and death-inducing autophagy in HCC and promotes cancer metastasis by inducing the epithelial–mesenchymal transition (EMT). In addition, upregulation of STAT3 is associated with the occurrence of chemoresistance and radioresistance in HCC. Specifically, non-protein-coding transcripts regulate STAT3 signaling in HCC, and their inhibition by antitumor agents may affect tumor progression. In this review, all these topics are discussed in detail to provide further insight into the role of STAT3 in tumorigenesis, treatment resistance, and pharmacological regulation of HCC. Graphical Abstract
- Published
- 2023
- Full Text
- View/download PDF
25. The Effect of Internet-delivered Mindfulness Stress Reduction Combined with Acceptance and Commitment Therapy on Health Anxiety and Quality of Life of Caregiver of Patients Infected by COVID-19: A Randomized Clinical Trial
- Author
-
Shokooh Shahidi, Fatemeh Zargar, Hassan Aghaee Khajelangi, and Mohammad Javad Tarrahi
- Subjects
mindfulness ,internet-based intervention ,quality of life ,health anxiety ,coronavirus ,Medicine ,Nursing ,RT1-120 - Abstract
Background: Coronavirus disease-19 (COVID-19) is a widespread disease all over the world that has causedmany psychological complications such as health anxiety (HA) and low quality of life (QOL). Mindfulnessbasedapproaches could improve these complications. Therefore, this study aimed to investigate the effect ofInternet-delivered mindfulness stress reduction combined with acceptance and commitment therapy (IMSRACT)on QOL and HA of caregivers of patients infected by COVID-19.Methods: In this randomized clinical trial, 72 people from Golpayegan city, Iran, who had a patient with COVID-19 in their family were selected from March to June 2020. A caregiver with a score above 27 on the Health Anxietyinventory (HAI-18) was selected using simple random sampling. Participants were assigned in the interventionor control group by permuted block random allocation. The intervention group was trained by MSR and ACTtechniques for 9 weeks accomplished via WhatsApp. All participants completed the QOLQuestionnaire-12 (SF-12) items and HAI-18 before and after completing IMSR-ACT sessions. The data were analyzed through SPSS-23 software, using Chi square, independent and paired t-test, and analysis of covariance, and P-value
- Published
- 2023
- Full Text
- View/download PDF
26. Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy
- Author
-
Mohammad Arad Zandieh, Melika Heydari Farahani, Mahshid Daryab, Alireza Motahari, Sarah Gholami, Farshid Salmani, Fatemeh Karimi, Seyedeh Setareh Samaei, Aryan Rezaee, Parham Rahmanian, Ramin Khorrami, Shokooh Salimimoghadam, Noushin Nabavi, Rongjun Zou, Gautam Sethi, Mohsen Rashidi, and Kiavash Hushmandi
- Subjects
Naturally occurring compounds ,Nanoparticles ,Cancer drug delivery ,Stimuli-responsive nanoparticles ,Chemoresistance ,Therapeutics. Pharmacology ,RM1-950 - Abstract
The use of phytochemicals for purpose of cancer therapy has been accelerated due to resistance of tumor cells to conventional chemotherapy drugs and therefore, monotherapy does not cause significant improvement in the prognosis and survival of patients. Therefore, administration of natural products alone or in combination with chemotherapy drugs due to various mechanisms of action has been suggested. However, cancer therapy using phytochemicals requires more attention because of poor bioavailability of compounds and lack of specific accumulation at tumor site. Hence, nanocarriers for specific delivery of phytochemicals in tumor therapy has been suggested. The pharmacokinetic profile of natural products and their therapeutic indices can be improved. The nanocarriers can improve potential of natural products in crossing over BBB and also, promote internalization in cancer cells through endocytosis. Moreover, (nano)platforms can deliver both natural and synthetic anti-cancer drugs in combination cancer therapy. The surface functionalization of nanostructures with ligands improves ability in internalization in tumor cells and improving cytotoxicity of natural compounds. Interestingly, stimuli-responsive nanostructures that respond to endogenous and exogenous stimuli have been employed for delivery of natural compounds in cancer therapy. The decrease in pH in tumor microenvironment causes degradation of bonds in nanostructures to release cargo and when changes in GSH levels occur, it also mediates drug release from nanocarriers. Moreover, enzymes in the tumor microenvironment such as MMP-2 can mediate drug release from nanocarriers and more progresses in targeted drug delivery obtained by application of nanoparticles that are responsive to exogenous stimulus including light.
- Published
- 2023
- Full Text
- View/download PDF
27. Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches
- Author
-
Mehrdad Hashemi, Niloufar Nadafzadeh, Mohammad Hassan Imani, Romina Rajabi, Setayesh Ziaolhagh, Seyedeh Delaram Bayanzadeh, Raheleh Norouzi, Reihaneh Rafiei, Zeinab Khazaei Koohpar, Behnaz Raei, Mohammad Arad Zandieh, Shokooh Salimimoghadam, Maliheh Entezari, Afshin Taheriazam, Athanasios Alexiou, Marios Papadakis, and Shing Cheng Tan
- Subjects
Hepatocellular carcinoma ,Autophagy ,Chemoresistance ,Metastasis ,Stemness ,Medicine ,Cytology ,QH573-671 - Abstract
Abstract Autophagy is an evolutionarily conserved process that plays a role in regulating homeostasis under physiological conditions. However, dysregulation of autophagy is observed in the development of human diseases, especially cancer. Autophagy has reciprocal functions in cancer and may be responsible for either survival or death. Hepatocellular carcinoma (HCC) is one of the most lethal and common malignancies of the liver, and smoking, infection, and alcohol consumption can lead to its development. Genetic mutations and alterations in molecular processes can exacerbate the progression of HCC. The function of autophagy in HCC is controversial and may be both tumor suppressive and tumor promoting. Activation of autophagy may affect apoptosis in HCC and is a regulator of proliferation and glucose metabolism. Induction of autophagy may promote tumor metastasis via induction of EMT. In addition, autophagy is a regulator of stem cell formation in HCC, and pro-survival autophagy leads to cancer cell resistance to chemotherapy and radiotherapy. Targeting autophagy impairs growth and metastasis in HCC and improves tumor cell response to therapy. Of note, a large number of signaling pathways such as STAT3, Wnt, miRNAs, lncRNAs, and circRNAs regulate autophagy in HCC. Moreover, regulation of autophagy (induction or inhibition) by antitumor agents could be suggested for effective treatment of HCC. In this paper, we comprehensively review the role and mechanisms of autophagy in HCC and discuss the potential benefit of targeting this process in the treatment of the cancer. Graphical abstract Video Abstract
- Published
- 2023
- Full Text
- View/download PDF
28. Graphene oxide/MIL 101(Cr) (GO/MOF) nano-composite for adsorptive removal of 2,4-dichlorophenoxyacetic acid (2,4 D) from aqueous media: synthesis, characterization, kinetic and isotherm studies
- Author
-
Shokooh Sadat Khaloo, Amin Bagheri, Reza Gholamnia, and Reza Saeedi
- Subjects
4 d ,graphene oxide ,pesticide ,metal organic framework ,removal ,Environmental technology. Sanitary engineering ,TD1-1066 - Abstract
Contamination of water resources with various pollutants and therefore lack of clean water resources are major problems that threaten many human societies. The need to develop efficient methods and materials to decontaminate water resource is an undeniable fact. Metal-organic frameworks (MOFs), as new class of highly crystalline porous solids, have attracted a great deal of attention in different research fields, especially in adsorptive removal and purification. In this study, MIL 101(Cr) MOF decorated with graphene oxide nano-layers (GO/MOF) was synthesized by a simple one-pot hydrothermal method. Scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and electron dispersion energy (EDS) were utilized to approve the growing of Cr-MOF on graphene oxide nano-layer. The synthesized nano-composite was used as a potential adsorbent for the removal of a pesticide, 2, 4-dichlorophenoxyacetic acid (2,4 D). The adsorption performance, kinetic and mechanism of 2,4 D adsorption onto GO/MOF were studied. The highest adsorption capacities of 476.9 mg g−1 was obtained at room temperature, pH 6.0 using 0.6 gL−1 of GO/MOF which was 34% higher than that of pristine Cr-MOF. The kinetics and isotherm data fitted well with pseudo-second kinetic and Langmuir isotherm model, respectively. The reusability and stability analyses showed that the synthesized GO/MOF nanocomposite kept 89% of sorption capacities for 2,4 D after four adsorption–desorption cycles. GO/MOF nano-composite was successfully applied to remove 2,4 D from agricultural waste. The results approved that the synthesized nano-composite could introduce as a stable and high performance adsorbent for adsorptive removal of selected pesticide. HIGHLIGHTS Graphene oxide nano-sheet decorated by MIL 101(Cr) has been synthesized by the hydrothermal method and characterized by SEM, EDS, XRD and FT-IR technology.; Adsorption kinetic, isotherm, reusability and stability of the nano-composite GO/MOF (Cr) in removal of 2,4 D pesticide were studied.; Applicability of the nano-composite GO/MOF (Cr) in removal of 2,4 D pesticide in agricultural wastewater was approved.;
- Published
- 2022
- Full Text
- View/download PDF
29. EXISTENCE AND MULTIPLICITY OF WEAK SOLUTIONS FOR SOME p(x)-LAPLACIAN-LIKE PROBLEMS VIA VARIATIONAL METHODS
- Author
-
AFROUZI, G.A., primary, SHOKOOH, S., additional, and CHUNG, N.T., additional
- Published
- 2017
- Full Text
- View/download PDF
30. Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response
- Author
-
Mehrdad Hashemi, Mahshid Deldar Abad Paskeh, Sima Orouei, Pegah Abbasi, Ramin Khorrami, Amir Dehghanpour, Negin Esmaeili, Azin Ghahremanzade, Mohammad Arad Zandieh, Maryam Peymani, Shokooh Salimimoghadam, Mohsen Rashidi, Afshin Taheriazam, Maliheh Entezari, and Kiavash Hushmandi
- Subjects
Breast cancer ,Autophagy ,Chemoresistance ,Programmed cell death ,Cancer therapy ,Therapeutics. Pharmacology ,RM1-950 - Abstract
As a devastating disease, breast cancer has been responsible for decrease in life expectancy of females and its morbidity and mortality are high. Breast cancer is the most common tumor in females and its treatment has been based on employment of surgical resection, chemotherapy and radiotherapy. The changes in biological behavior of breast tumor relies on genomic and epigenetic mutations and depletions as well as dysregulation of molecular mechanisms that autophagy is among them. Autophagy function can be oncogenic in increasing tumorigenesis, and when it has pro-death function, it causes reduction in viability of tumor cells. The carcinogenic function of autophagy in breast tumor is an impediment towards effective therapy of patients, as it can cause drug resistance and radio-resistance. The important hallmarks of breast tumor such as glucose metabolism, proliferation, apoptosis and metastasis can be regulated by autophagy. Oncogenic autophagy can inhibit apoptosis, while it promotes stemness of breast tumor. Moreover, autophagy demonstrates interaction with tumor microenvironment components such as macrophages and its level can be regulated by anti-tumor compounds in breast tumor therapy. The reasons of considering autophagy in breast cancer therapy is its pleiotropic function, dual role (pro-survival and pro-death) and crosstalk with important molecular mechanisms such as apoptosis. Moreover, current review provides a pre-clinical and clinical evaluation of autophagy in breast tumor.
- Published
- 2023
- Full Text
- View/download PDF
31. HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
- Author
-
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, Timo L.M. ten Hagen, Shokooh Salimimoghadam, Afshin Taheriazam, Maliheh Entezari, and Mojtaba Falahati
- Subjects
HMGA2 ,Cancer ,MiRNA ,LncRNA ,CircRNAs ,Therapeutics. Pharmacology ,RM1-950 - Abstract
High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this protein is an upstream mediator of cancer hallmarks including evasion of apoptosis, proliferation, invasion, metastasis, and therapy resistance. HMGA2 targets critical signaling pathways such as Wnt/β-catenin and mTOR in cancer cells. Therefore, suppression of HMGA2 function notably decreases cancer progression and improves outcome in patients. As HMGA2 is mainly oncogenic, targeting expression by non-coding RNAs (ncRNAs) is crucial to take into consideration since it affects HMGA2 function. MicroRNAs (miRNAs) belong to ncRNAs and are master regulators of vital cell processes, which affect all aspects of cancer hallmarks. Long ncRNAs (lncRNAs) and circular RNAs (circRNAs), other members of ncRNAs, are upstream mediators of miRNAs. The current review intends to discuss the importance of the miRNA/HMGA2 axis in modulation of various types of cancer, and mentions lncRNAs and circRNAs, which regulate this axis as upstream mediators. Finally, we discuss the effect of miRNAs and HMGA2 interactions on the response of cancer cells to therapy. Regarding the critical role of HMGA2 in regulation of critical signaling pathways in cancer cells, and considering the confirmed interaction between HMGA2 and one of the master regulators of cancer, miRNAs, targeting miRNA/HMGA2 axis in cancer therapy is promising and this could be the subject of future clinical trial experiments.
- Published
- 2023
- Full Text
- View/download PDF
32. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways
- Author
-
Eisa Sabouni, Melina Maghsodlou Nejad, Sarah Mojtabavi, Sara Khoshduz, Mahsa Mojtabavi, Niloufar Nadafzadeh, Negin Nikpanjeh, Sepideh Mirzaei, Mehrdad Hashemi, Amir Reza Aref, Ramin Khorrami, Noushin Nabavi, Yavuz Nuri Ertas, Shokooh Salimimoghadam, Mohammad Arad Zandieh, Parham Rahmanian, Afshin Taheriazam, and Kiavash Hushmandi
- Subjects
Colorectal cancer ,Chemoresistance ,EMT ,Metastasis ,Non-coding RNAs ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Colorectal cancer (CRC) is a dangerous form of cancer that affects the gastrointestinal tract. It is a major global health concern, and the aggressive behavior of tumor cells makes it difficult to treat, leading to poor survival rates for patients. One major challenge in treating CRC is the metastasis, or spread, of the cancer, which is a major cause of death. In order to improve the prognosis for patients with CRC, it is necessary to focus on ways to inhibit the cancer's ability to invade and spread. Epithelial-mesenchymal transition (EMT) is a process that is linked to the spread of cancer cells, also known as metastasis. The process transforms epithelial cells into mesenchymal ones, increasing their mobility and ability to invade other tissues. This has been shown to be a key mechanism in the progression of colorectal cancer (CRC), a particularly aggressive form of gastrointestinal cancer. The activation of EMT leads to increases in the spread of CRC cells, and during this process, levels of the protein E-cadherin decrease while levels of N-cadherin and vimentin increase. EMT also contributes to the development of resistance to chemotherapy and radiation therapy in CRC. Non-coding RNAs, such as long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), play a role in regulating EMT in CRC, often through their ability to ''sponge'' microRNAs. Anti-cancer agents have been shown to suppress EMT and reduce the progression and spread of CRC cells. These findings suggest that targeting EMT or related mechanisms may be a promising approach for treating CRC patients in the clinic.
- Published
- 2023
- Full Text
- View/download PDF
33. The pharmacological and biological importance of EZH2 signaling in lung cancer
- Author
-
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, Eisa Sabouni, Mohammad Arad Zandieh, Maryam Aboutalebi, Amirabbas Kakavand, Shamin Rezaei, Elahe Sadat Hejazi, Hamidreza Saebfar, Shokooh Salimimoghadam, Sepideh Mirzaei, Mehrdad Hashemi, and Saeed Samarghandian
- Subjects
Lung cancer ,EZH2 signaling ,Cancer therapy ,Drug resistance ,Non-coding RNAs ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Up to 18% of cancer-related deaths worldwide are attributed to lung tumor and global burden of this type of cancer is ascending. Different factors are responsible for development of lung cancer such as smoking, environmental factors and genetic mutations. EZH2 is a vital protein with catalytic activity and belongs to PCR2 family. EZH2 has been implicated in regulating gene expression by binding to promoter of targets. The importance of EZH2 in lung cancer is discussed in current manuscript. Activation of EZH2 significantly elevates the proliferation rate of lung cancer. Furthermore, metastasis and associated molecular mechanisms including EMT undergo activation by EZH2 in enhancing the lung cancer progression. The response of lung cancer to therapy can be significantly diminished due to EZH2 upregulation. Since EZH2 increases tumor progression, anti-cancer agents suppressing its expression reduce malignancy. In spite of significant effort in understanding modulatory function of EZH2 on other pathways, it appears that EZH2 can be also regulated and controlled by other factors that are described in current review. Therefore, translating current findings to clinic can improve treatment and management of lung cancer patients.
- Published
- 2023
- Full Text
- View/download PDF
34. Economic power of the Achaemenid Empire by relying on communication networks and its reflection on the prominent stone of Persepolis
- Author
-
Eskandar Mombeini, Shokooh Sadat Arabi Hashemi, and Ahmad Kamranifar
- Subjects
achaemenid empire ,satrap ,printing house ,communication network ,Arts in general ,NX1-820 - Abstract
The Achaemenid Empire was one of the largest empires in ancient history, stretching from the east side of the Indus River and from the west and southwest to the Mediterranean Sea and the Nile River in northern Africa, from the north to the Aral Sea and from the south. It stretched to the southern shores of the Oman Sea and the Persian Gulf. This vastness of land and the diversity of culture and population necessitated a regular and secure communication network. The Achaemenid kings took many measures to develop communication routes. The best evidence for this is the archaeological evidence left by them along these routes. The existence of evidence such as the remains of roads, ravines, bridges, dams, castles, printing presses, fire temples, etc., is evidence of the existence of busy roads in this era. In this research, we have tried to study the important position of communication network and its role in the development of trade and commerce in the Achaemenid period with the help of texts, maps and images, as well as descriptive-analytical method. In the end, we have come to the conclusion that the communication routes of the Achaemenid Empire, especially the royal road as the vital arteries of this land, have connected all the capitals and important centers of the empire, and the political, economic and military life of these centers depends on security. These have been the ways.
- Published
- 2023
- Full Text
- View/download PDF
35. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
- Author
-
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, Rasoul Raesi, Motahhar Motahhary, Sam Saghari, Laleh Sharifi, Saied Bokaie, Sepideh Mirzaei, Maliheh Entezari, Amir Reza Aref, Shokooh Salimimoghadam, Mohsen Rashidi, Afshin Taheriazam, and Kiavash Hushmandi
- Subjects
Prostate cancer ,STAT3 signaling ,Drug resistance ,Metastasis ,Tumor progression ,Therapeutics. Pharmacology ,RM1-950 - Abstract
The categorization of cancers demonstrates that prostate cancer is the most common malignancy in men and it causes high death annually. Prostate cancer patients are diagnosed mainly via biomarkers such as PSA test and patients show poor prognosis. Prostate cancer cells rapidly diffuse into different parts of body and their metastasis is also a reason for death. Current therapies for prostate cancer patients include chemotherapy, surgery and radiotherapy as well as targeted therapy. The progression of prostate cancer cells is regulated by different factors that STAT3 signaling is among them. Growth factors and cytokines such as IL-6 can induce STAT3 signaling and it shows carcinogenic impact. Activation of STAT3 signaling occurs in prostate cancer and it promotes malignant behavior of tumor cells. Induction of STAT3 signaling increases glycolysis and proliferation of prostate cancer cells and prevents apoptosis. Furthermore, STAT3 signaling induces EMT mechanism in increasing cancer metastasis. Activation of STAT3 signaling stimulates drug resistance and the limitation of current works is lack of experiment related to role of STAT3 signaling in radio-resistance in prostate tumor. Calcitriol, capsazepine and β-elemonic are among the compounds capable of targeting STAT3 signaling and its inhibition in prostate cancer therapy. In addition to natural products, small molecules targeting STAT3 signaling have been developed in prostate cancer therapy.
- Published
- 2023
- Full Text
- View/download PDF
36. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
- Author
-
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, Setayesh Ziaolhagh, Romina Rajabi, Parham Rahmanian, Soheila Abdi, Zeinab Khazaei Koohpar, Reihaneh Rafiei, Behnaz Raei, Fatemeh Ahmadi, Shokooh Salimimoghadam, Amir Reza Aref, Mohammad Arad Zandieh, Maliheh Entezari, Afshin Taheriazam, and Kiavash Hushmandi
- Subjects
Glioblastoma ,PTEN/PI3K/Akt ,Drug resistance ,Prognosis ,Non-coding RNAs ,Cancer therapy ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Glioblastoma (GBM) is one of the most malignant cancers of central nervous system and due to its sensitive location, surgical resection has high risk and therefore, chemotherapy and radiotherapy are utilized for its treatment. However, chemoresistance and radio-resistance are other problems in GBM treatment. Hence, new therapies based on genes are recommended for treatment of GBM. PTEN is a tumor-suppressor operator in cancer that inhibits PI3K/Akt/mTOR axis in diminishing growth, metastasis and drug resistance. In the current review, the function of PTEN/PI3K/Akt axis in GBM progression is evaluated. Mutation or depletion of PTEN leads to increase in GBM progression. Low expression level of PTEN mediates poor prognosis in GBM and by increasing proliferation and invasion, promotes malignancy of tumor cells. Moreover, loss of PTEN signaling can result in therapy resistance in GBM. Activation of PTEN signaling impairs GBM metabolism via glycolysis inhibition. In contrast to PTEN, PI3K/Akt signaling has oncogenic function and during tumor progression, expression level of PI3K/Akt enhances. PI3K/Akt signaling shows positive association with oncogenic pathways and its expression similar to PTEN signaling, is regulated by non-coding RNAs. PTEN upregulation and PI3K/Akt signaling inhibition by anti-cancer agents can be beneficial in interfering GBM progression. This review emphasizes on the signaling networks related to PTEN/PI3K/Akt and provides new insights for targeting this axis in effective GBM treatment.
- Published
- 2023
- Full Text
- View/download PDF
37. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response
- Author
-
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, Seyed reza Mirmazloomi, Aria Hassanpoor, Maryam Aboutalebi, Shamin Rezaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Hajar Heidari, Shokooh Salimimoghadam, Afshin Taheriazam, Mehrdad Hashemi, and Saeed Samarghandian
- Subjects
SOX2 ,Transcriptional regulation ,Cancer development ,Therapy resistance ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Cancer is a leading cause of death worldwide and around 10 million deaths in 2020 were related to cancer. There are a number of therapeutic modalities for cancer such as chemotherapy, radiotherapy and surgery. However, tumor cells have capacity of developing resistance to chemotherapy and radiotherapy. Genetic mutations participate in development and progression of cancer. The current review focuses on the role of SOX2 transcription factor in cancer. SOX2 has capacity of increasing growth and metastasis of cancer cells. It functions as double-edged sword and has ability of suppressing tumor progression. Increasing evidence reveals that SOX2 is involved in triggering resistance to chemotherapy and radiotherapy. SOX2 promotes stemness of tumor cells and increases the number of cancer stem cells. SOX2 overexpression occurs in the tumor cells and tissues to ensure their proliferation and metastasis. Silencing SOX2 using CRISPR or siRNA impairs progression of the cancer cells and reduces their survival rate. SOX2 demonstrates interactions with other factors such as miRNAs, lncRNAs, STAT3 and Wnt/β-catenin, among others to regulate progression of the tumor cells. SOX2 can be considered as a biomarker in cancer patients. SOX2 overexpression is associated with lymph node metastasis, low survival rate and poor prognosis of cancer patients.
- Published
- 2022
- Full Text
- View/download PDF
38. EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
- Author
-
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, Shayan Fallah, Amin Ghorbani, Maryam Khaledabadi, Amirabbas Kakavand, Alireza Tavakolpournegari, Hamidreza Saebfar, Hajar Heidari, Shokooh Salimimoghadam, Maliheh Entezari, Afshin Taheriazam, and Kiavash Hushmandi
- Subjects
Breast tumor ,EMT ,Metastasis ,Drug resistance ,Tumor progression ,Therapeutics. Pharmacology ,RM1-950 - Abstract
One of the malignant tumors in women that has involved both developed and developing countries is breast cancer. Similar to other types of tumors, breast cancer cells demonstrate high metastatic nature. Besides, breast tumor cells have ability of developing drug resistance. EMT is the related mechanism to cancer metastasis and focus of current manuscript is highlighting function of EMT in breast tumor malignancy and drug resistance. Breast tumor cells increase their migration by EMT induction During EMT, N-cadherin and vimentin levels increase, and E-cadherin levels decrease to mediate EMT-induced breast tumor invasion. Different kinds of anti-cancer agents such as tamoxifen, cisplatin and paclitaxel that EMT induction mediates chemoresistance feature of breast tumor cells. Furthermore, EMT induction correlates with radio-resistance in breast tumor. Clinical aspect is reversing EMT in preventing chemotherapy or radiotherapy failure in breast cancer patients and improving their survival time. The anti-tumor agents that suppress EMT can be used for decreasing breast cancer invasion and increasing chemosensitivity of tumor cells. Furthermore, lncRNAs, miRNAs and other factors can modulate EMT in breast tumor progression that are discussed here.
- Published
- 2022
- Full Text
- View/download PDF
39. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
- Author
-
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, Shayan Fallah, Arezoo Sanaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Shamin Rezaei, Hajar Heidari, Mitra Behroozaghdam, Salman Daneshi, Shokooh Salimimoghadam, Sepideh Mirzaei, Mehrdad Hashemi, and Saeed Samarghandian
- Subjects
LncRNAs ,MicroRNAs ,Cancer therapy ,Chemoresistance ,Non-coding RNAs ,Gene therapy ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Epigenetic factors are critical regulators of biological and pathological mechanisms and they could interact with different molecular pathways. Targeting epigenetic factors has been an idea approach in disease therapy, especially cancer. Accumulating evidence has highlighted function of long non-coding RNAs (lncRNAs) as epigenetic factors in cancer initiation and development and has focused on their association with downstream targets. microRNAs (miRNAs) are the most well-known targets of lncRNAs and present review focuses on lncRNA-miRNA axis in malignancy and therapy resistance of tumors. LncRNA-miRNA regulates cell death mechanisms such as apoptosis and autophagy in cancers. This axis affects tumor metastasis via regulating EMT and MMPs. Besides, lncRNA-miRNA axis determines sensitivity of tumor cells to chemotherapy, radiotherapy and immunotherapy. Based on the studies, lncRNAs can be affected by drugs and genetic tools in cancer therapy and this may affect expression level of miRNAs as their downstream targets, leading to cancer suppression/progression. LncRNAs have both tumor-promoting and tumor-suppressor functions in cancer and this unique function of lncRNAs has complicated their implication in tumor therapy. LncRNA-miRNA axis can also affect other signaling networks in cancer such as PI3K/Akt, STAT3, Wnt/β-catenin and EZH2 among others. Notably, lncRNA/miRNA axis can be considered as a signature for diagnosis and prognosis in cancers.
- Published
- 2022
- Full Text
- View/download PDF
40. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
- Author
-
Tricoci, P, Huang, Z, Held, C, Moliterno, Dj, Armstrong, Pw, Van de Werf, F, White, Hd, Aylward, Pe, Wallentin, L, Chen, E, Lokhnygina, Y, Pei, J, Leonardi, S, Rorick, Tl, Kilian, Am, Jennings, Lh, Ambrosio, G, Bode, C, Cequier, A, Cornel, Jh, Diaz, R, Erkan, A, Huber, K, Hudson, Mp, Jiang, L, Jukema, Jw, Lewis, Bs, Lincoff, Am, Montalescot, G, Nicolau, Jc, Ogawa, H, Pfisterer, M, Prieto, Jc, Ruzyllo, W, Sinnaeve, Pr, Storey, Rf, Valgimigli, M, Whellan, Dj, Widimsky, P, Strony, J, Harrington, Ra, Mahaffey, Kw, Huo, Y, Lixin, J, Isaza, D, Grande, P, Laine, M, Wong, L, Ofner, P, Yamaguchi, T, Park, Sj, Nordrehaug, Je, Providencia, L, Cheem, Th, Dalby, A, Betriu, A, Chen, Mf, Verheugt, F, Frye, Rl, Hochman, J, Steg, Pg, Bailey, Kr, Easton, Jd, Lincoff, A, Underwood, Fd, Wrestler, J, Larson, D, Vandyne, B, Kilian, A, Harmelin-Kadouri, R, Layton, L, Lipka, L, Petrauskas, S, Qidwai, M, Sorochuck, C, Temple, T, Mason, D, Sydlowski, D, Gallagher, B, Villasin, A, Beernaert, A, Douglas, S, Garrett, J, Wiering, J, Adriaenssens, T, Ganame, J, Hulselmans, M, Katz, Jn, Kayaert, P, La Gerche, A, Onsea, K, Zalewski, J, Johnson, A, O'Briant, J, Smith, M, Akerblom, A, Armaganijan, L, Bertolami, A, Brennan, M, da Ponte Nacif SA, de Campos Gonzaga, C, Dequadros, A, Déry, Jp, Dev, S, Ducrocq, G, Eapen, Zp, Echenique, L, Eggers, K, Garcia, H, Guimaraes, Hp, Hagstrom, E, Hanet, C, James, S, Jonelid, B, Kolls, Bj, Leiria, T, Leite, R, Lombardi, C, Lopes, Rd, Malagutti, P, Mathews, R, Mehta, Rh, Melloni, C, Piccini, Jp, Rodriques Soares, P, Roe, Mt, Shah, Br, Stashenko, G, Szczech, La, Truffa, A, Varenhorst, C, Vranckx, P, Williams, J, Kilaru, R, White, Ja, Binkowitz, B, He, W, Ramos, Ms, Hasbani, E, Farras, Ha, Luz del Valle, L, Zapata, G, Centeno, Ep, Hominal, M, Beloscar, J, Panno, M, Berli, M, Carlevaro, O, Wasserman, T, Lembo, L, Diez, F, Bettinotti, M, Allall, O, Macin, S, Hii, C, Bett, N, Aroney, C, Roberts-Thomson, P, Arstall, M, Horowitz, J, Prasan, A, Farshid, A, Rankin, J, Duffy, S, Sinhal, A, Hendricks, R, Waites, J, Hill, A, French, J, Adams, M, Soward, A, Dick, R, Jepson, N, Nelson, G, Thompson, P, Neunteufl, T, Pachinger, O, Leisch, F, Siostrzonek, P, Roithinger, F, Pieske, B, Weber, H, Eber, B, Zenker, G, Sinnaeve, P, Roosen, J, Vervoort, G, Coussement, P, Striekwold, H, Boland, J, Van Dorpe, A, Dujardin, K, Mertens, D, Vanneste, L, Celen, H, Lesseliers, H, Vrolix, M, Leone, A, De Maeseneire, S, Hellemans, S, Silva, Fa, Franken, M, Moraes JB Jr, Mora, R, Michalaros, Y, Perin, M, Guimaraes, Ae, da Silva DG, Mattos, Ma, Alves AR Jr, Hernandes, Me, Golin, V, da Silva SA, Ardito, W, Dery, Jp, Mukherjee, A, Tanguay, Jf, Kornder, J, Lutchmedial, S, Degrace, M, Klinke, P, Constance, C, Nogareda, G, Wong, G, Macdonald, P, Senaratne, M, Rupka, D, Halperin, F, Ramanathan, K, Natarajan, M, Lai, C, Brossoit, R, Tymchak, W, Rose, B, Dupuis, R, Mansour, S, Bata, I, Zadra, R, Turek, M, Madan, M, Le May, M, Leon, L, Perez, L, Yovaniniz, P, Pedemonte, O, Campos, P, Pincetti, C, Sepulveda, P, Li, W, Zhao, R, Li, Z, Yang, Y, Chen, J, Li, H, Jiang, Y, Li, D, Qu, P, Sun, Y, Zheng, Y, Zhou, C, Zhang, F, Wei, M, Wang, D, Lemus, J, Fernandez, Rl, Jaramillo, C, Ochoa, J, Velez, S, Cano, N, Lutz, J, Botero, R, Jaramillo, M, Saaib, J, Sanchez, G, Hernandez, H, Mendoza, F, Rizcala, A, Urina, M, Polasek, R, Motovska, Z, Zemanek, D, Ostransky, J, Kettner, J, Spinar, J, Groch, L, Ramik, C, Stumar, J, Linhart, A, Pleva, L, Niedobova, E, Macha, J, Vojacek, J, Stipal, R, Galatius, S, Eggert, S, Mickley, H, Egstrup, K, Pedersen, O, Hvilsted, L, Sykulski, R, Skagen, K, Dodt, K, Klarlund, K, Husted, S, Jensen, G, Melchior, T, Sjoel, A, Steffensen, Fh, Airaksinen, Ke, Laukkanen, Ja, Syvanne, Ms, Kotila, Mj, Mikael, K, Naveri, Hk, Hekkala, Am, Mustonen, Jn, Halkosaari, M, Ohlmann, P, Khalife, K, Dibon, O, Hirsch, Jl, Furber, A, Nguyen-Khac, Jo, Delarche, N, Probst, V, Lim, P, Bayet, G, Dauphin, R, Levai, L, Galinier, M, Belhassane, A, Wiedemann, Jy, Fouche, R, Coisne, D, Henry, P, Schiele, F, Boueri, Z, Vaquette, B, Davy, Jm, Cottin, Y, D'Houdain, F, Danchin, N, Cassat, C, Messner, P, Elbaz, M, Coste, P, Zemour, G, Maupas, E, Feldman, L, Soto, Fx, Ferrari, E, Haltern, G, Heuer, H, Genth-Zotz, S, Loges, C, Stellbrink, C, Terres, W, Ferrar, M, Zeymer, U, Brachmann, J, Mudra, H, Vohringer, Hf, vom Dah, J, Kreuzer, J, Hill, S, Kleinertz, K, Kadel, C, Appel, Kf, Nienabe, C, Behrens, S, Frantz, S, Mehrhof, F, Krings, P, Hengstenberg, C, Lueders, S, Hanefel, C, Krulls-Munch, J, Dorse, T, Leschke, M, Nogai, K, Butter, C, Darius, H, Fichtlscherer, Hp, Schmitt, C, Kasisk, Hp, Dorr, M, Fran, N, Jereczek, M, Wiemer, M, Nickenig, G, Boudriot, E, Werner, G, Altila, T, Strasser, R, Baldus, S, Desaga, M, Buerke, M, Land, S, Schunkert, H, Schulze, Ho, Holmer, S, Sohn, Hy, Burkhardt, W, Lauer, B, Schwimmbeck, P, Schoeller, R, Lapp, H, Gross, M, Kindermann, I, Schuster, P, Yu, Cm, Lee, S, Merkely, B, Apro, D, Lupkovics, G, Edes, I, Ungi, I, Piroth, Z, Csapo, K, Dezsi, Ca, Herczeg, B, Sereg, M, Butnaru, A, Lewis, B, Rosenschein, U, Mosseri, M, Turgeman, Y, Pollak, A, Shotan, A, Hammerman, H, Rozenman, Y, Gottlieb, S, Atar, S, Weiss, A, Marmor, A, Iakobishvili, Z, Mascia, F, De Cesare, N, Piovaccari, G, Ceravolo, R, Fiscella, A, Salvioni, A, Silvestri, O, Moretti, L, Severi, S, Carmina, Mg, De Caterina, R, Fattore, L, Terrosu, P, Trimarco, B, Ardissino, D, Uguccioni, L, Auguadro, C, Gregorio, G, De Ferrari, G, Testa, R, Evola, R, De Servi, S, Sganzerla, P, Vassanelli, C, Brunelli, C, Scherillo, M, Tamburino, C, Limido, A, Luzza, F, Percoco, Gf, Sinagra, G, Volpe, M, Crea, F, Fedele, F, Rasetti, G, Cinelli, F, Merlini, P, Sisto, F, Biancoli, S, Fresco, C, Corrada, E, Casolo, G, Santini, M, D'Alessandro, B, Antoniucci, D, Tuccillo, B, Assennato, P, Puccioni, E, Pasquetto, G, Perna, Gp, Morgagni, G, Takizawa, K, Kato, K, Oshima, S, Yagi, M, Asai, T, Kamiya, H, Hirokami, M, Sakota, S, Sueyoshi, A, Shimomura, H, Hashimoto, T, Miyahara, M, Matsumura, T, Nakao, K, Kakuta, T, Nakamura, S, Nishi, Y, Kawajiri, K, Nagai, Y, Takahashi, A, Ikari, Y, Hara, K, Koga, T, Fujii, K, Tobaru, T, Tsunoda, R, Uchiyama, T, Hirayama, H, Fujimoto, K, Sakurai, S, Tanigawa, T, Ohno, M, Yamamoto, E, Ikuta, S, Kato, A, Kikuta, K, Takami, A, Chong, Wp, Ong, Tk, Yusof, A, Maskon, O, Kahar, A, Breedveld, Rw, Bendermacher, Pe, Hamer, Bj, Oude Ophuis AJ, Nierop, Pr, Westendorp, Ic, Beijerbacht, Hp, Herrman, Jp, van 't Hof AW, Troquay, Rp, van der Meer, P, Peters, Rh, van Rossum, P, Liem, A, Pieterse, Mg, van Eck JW, van der Zwaan, C, Pasupati, S, Elliott, J, Tisch, J, Hart, H, Luke, R, Scott, D, Ternouth, I, White, H, Hamer, A, Harding, S, Wilkins, G, O'Meeghan, T, Harrison, N, Nilsen, D, Thalamus, J, Aaberge, L, Brunvand, H, Lutterbey, G, Omland, Tm, Eritsland, J, Wiseth, R, Aase, O, Campos, C, Horna, M, Toce, L, Salazar, M, Przewlocki, T, Ponikowski, P, Kasprzak, J, Kopaczewski, J, Musial, W, Mazurek, W, Kawecka-Jaszcz, K, Pluta, W, Dobrzycki, S, Loboz-Grudzien, K, Lewczuk, J, Karwowski, D, Grajek, S, Dudek, D, Trusz-Gluza, M, Kornacewicz-Jach, Z, Gil, R, Ferreira, J, Gavina, C, Ferreira, R, Martins, D, Garcia-Rinaldi, R, Ufret, R, Vazquez-Tanus, J, Banchs, H, Wong, A, Tan, Hc, Guerra, M, Ebrahim, I, Roux, J, Blomerus, P, Saaiman, A, Corbett, C, Pillay, T, Freeman, V, Horak, A, Zambakides, C, Burgess, L, Yoon, Jh, Ahn, Th, Gwon, Hc, Seong, Iw, Kim, Hs, Jeong, Mh, Kim, Yd, Chae, Sc, Hernandez, Jm, Pique, M, Fernandez Portales, J, Paz, Ma, Lopez Palop, R, Iniguez, A, Diaz Fernandez, J, Alvarez, P, Sanz, E, Heras, M, Sala, J, Goicolea, J, Cruz Fernandez, J, Serra, A, Fernandez Ortiz, A, Calle, G, Barriales, V, Albarran, A, Curos, A, Molano Casimiro FJ, Suarez, Ma, Franco, Sn, Bayon, J, Suarez, J, Belchi, J, Moreu, J, San Martin, M, Melgares Moreno, R, Aguirre Salcedo, J, Gonzalez Juanatey JR, Martinez Romero, P, Galache Osuna JG, Albertsson, P, Diderholm, E, Lycksell, M, Rasmanis, G, Swahn, E, Cherfan, P, Christensen, K, Lundman, P, Larson, Le, Vasko, P, Pripp, Cm, Johansson, A, Moccetti, T, Corti, R, Pieper, M, Mach, F, Eberli, F, Jeger, R, Rickli, H, Vogt, P, Windecker, S, Wu, Cj, Kao, Hl, Charng, Mj, Chang, Kc, Chen, Zc, Tsa, Cd, Shyu, Kg, Lai, Wt, Hsieh, Ic, Hou, Jy, Yeh, Hi, Ueng, Kc, Yin, Wh, Timurkaynak, T, Yigit, Z, Yilmaz, M, Boyaci, A, Sahin, M, Goktekin, O, Bozkurt, E, Ercan, E, Yildirir, A, Muthusamy, R, Keeling, P, Levy, T, Zaman, A, Cohen, A, Gorog, D, Baumbach, A, Oldroyd, K, Kadr, H, Tait, G, Bellenger, N, Davis, G, Shakespeare, C, Senior, R, Bruce, D, Uren, N, Trouton, T, Ahsan, A, Hamed, A, Malik, I, Sarma, J, Millar-Craig, M, Robson, H, Kennon, S, Sprigings, D, Brodie, B, Kang, Gs, Thomas, G, Cheng, Sc, Espinoza, A, Kassas, S, Jafar, Z, Kumar, P, Izzo, M, Wiseman, A, Chandna, H, Felten, W, D'Urso, M, Gudipati, Cr, Coram, R, Gill, S, Bengtson, J, Chang, M, Raisinghani, A, Blankenship, J, Harbor, Wf, Kraft, P, Ashraf, R, Chambers, J, Albirini, A, Malik, A, Ziada, K, Slepian, M, Taussig, A, Vernon, H, Jetty, P, Islam, Ma, Canaday, D, Martin, T, Burchenal, Jj, Gencheff, N, Nygaard, T, Panchal, V, Merritt, R, Abrahams, L, Lambert, C, Reyes, P, Leimbach, W, Chhabra, A, Caputo, R, Imburgia, M, Erickson, B, Kleiman, N, Hunter, J, Dehning, M, Graham, B, Strain, J, White, Jk, Mcgarvey, J Jr, Henderson, D, Treasure, C 2nd, Mirro, M, Pancholy, S, Helmy, T, Westerhausen, D, Dib, N, Penny, W, Kim, H, Degregorio, M, Jay, D, Kmonicek, J, Berlowitz, M, Starling, M, Langevin, E, Nelson, R, Singer, A, Siachos, A, Gibson, G, Parrott, C, Held, J, Puleo, P, Wolford, T, Omar, B, Brilakis, E, Lewis, S, Heller, L, Brener, S, Addo, T, Lieberman, S, Eisenberg, D, Feldman, R, Waksman, R, Waltman, J, Schulman, S, Bounds, C, Voyce, S, Batchelor, W, Dobies, D, Pasnoori, V, Chandrashekhar, Y, Vetrovec, G, Azrin, M, Spriggs, D, Hirsch, C, Smucker, M, Chetcuti, S, Stella, R, Levite, H, Shoukfeh, M, Vidovich, M, Saucedo, J, Fintel, D, Low, R, Gellman, J, Ahsan, C, Unks, Dm, Tolleson, T, Ceccoli, H, Aggarwal, K, Bhaktaram, V, Olson, C, Decaro, M, Kaluski, E, Mehta, V, Puma, J, Singh, V, Fulmer, J, Lewis, D, Khadra, S, Staniloae, C, East, M, Sundram, Ps, Anderson, J, Wasserman, H, Guy, D, Brill, D, Kruse, K, Ebrahimi, R, Nguyen, T, Keating, F, Srivastava, R, Wassmer, P, Todd, J 3rd, Stein, M, Hamzeh, I, Laxson, D, Hodson, R, Puri, S, Vijayaraghavan, K, Gazmuri, R, Chu, A, Vijay, N, Rabinowitz, A, Block, T, Agarwal, H, Martin, J, Zetterlund, P, Fortuin, D, Macdonell, A 3rd, Zouzoulas, S, Chepuri, V, Schmalfuss, C, Karve, M, Aviles, R, Lieberman, E, Amlani, M, Murphy, S, Shapiro, T, Herzog, E, Ariani, K, Bhagwat, R, Hockstad, E, Kai, W, Saririan, M, Roth, R, Weiland, F, Atassi, K, Harjai, K, Muhlestein, J, Marsh, R, Shokooh, S, Nahhas, A, Labroo, A, Mayor, M, Koshy, S, Tariq, M, Rayos, G, Jones, S, Klugherz, B, Dewey, R, Rashid, Hu, Wohns, D, Feiring, A, Bowles, M, Rohrbeck, S, Monroe, Vs, De Gottlieb, A, Gumm, D, Brown, C 3rd, Chang, D, Kalaria, V, Minisi, A, Joumaa, M, Josephson, R, Kleczka, J, Silver, K, Coleman, P, Brachfeld, C, Saltiel, F, Reiner, J, Carell, E, Hanovich, G, Rosenberg, M, Das, G, Blick, D, and Universitat de Barcelona
- Subjects
Male ,Pyridines ,medicine.medical_treatment ,Kaplan-Meier Estimate ,law.invention ,Lactones ,Randomized controlled trial ,law ,Thrombin receptor antagonist ,clopidogrel ,placebo ,thienopyridine derivative ,vorapaxar ,antithrombocytic agent ,lactone ,proteinase activated receptor 1 ,pyridine derivative ,Coronary Artery Bypass ,Vorapaxar ,Cardiovascular diseases [NCEBP 14] ,Drugs ,General Medicine ,Middle Aged ,Combined Modality Therapy ,Cardiovascular diseases ,Cardiovascular Diseases ,Cardiology ,Platelet aggregation inhibitor ,Drug Therapy, Combination ,Female ,Plaquetes sanguínies ,Intracranial Hemorrhages ,Major bleeding ,Medicaments ,medicine.drug ,medicine.medical_specialty ,Acute coronary syndrome ,Bypass cardiopulmonary ,Hemorrhage ,Pharmacotherapy ,Blood platelets ,Double-Blind Method ,Angioplasty ,Internal medicine ,medicine ,Humans ,Receptor, PAR-1 ,Acute Coronary Syndrome ,Aged ,business.industry ,Malalties cardiovasculars ,medicine.disease ,Surgery ,Bypass cardiopulmonar ,business ,Platelet Aggregation Inhibitors ,Follow-Up Studies - Abstract
Item does not contain fulltext BACKGROUND: Vorapaxar is a new oral protease-activated-receptor 1 (PAR-1) antagonist that inhibits thrombin-induced platelet activation. METHODS: In this multinational, double-blind, randomized trial, we compared vorapaxar with placebo in 12,944 patients who had acute coronary syndromes without ST-segment elevation. The primary end point was a composite of death from cardiovascular causes, myocardial infarction, stroke, recurrent ischemia with rehospitalization, or urgent coronary revascularization. RESULTS: Follow-up in the trial was terminated early after a safety review. After a median follow-up of 502 days (interquartile range, 349 to 667), the primary end point occurred in 1031 of 6473 patients receiving vorapaxar versus 1102 of 6471 patients receiving placebo (Kaplan-Meier 2-year rate, 18.5% vs. 19.9%; hazard ratio, 0.92; 95% confidence interval [CI], 0.85 to 1.01; P=0.07). A composite of death from cardiovascular causes, myocardial infarction, or stroke occurred in 822 patients in the vorapaxar group versus 910 in the placebo group (14.7% and 16.4%, respectively; hazard ratio, 0.89; 95% CI, 0.81 to 0.98; P=0.02). Rates of moderate and severe bleeding were 7.2% in the vorapaxar group and 5.2% in the placebo group (hazard ratio, 1.35; 95% CI, 1.16 to 1.58; P
- Published
- 2012
41. UV protection properties of workwear fabrics coated with TiO2 nanoparticles
- Author
-
Hadiseh Rabiei, Somayeh Farhang Dehghan, Majid Montazer, Shokooh Sadat Khaloo, and Aysa Ghasemi Koozekonan
- Subjects
TiO2 ,nanoparticles ,UPF ,in-situ ,textile ,Public aspects of medicine ,RA1-1270 - Abstract
The main purpose of this study was to evaluate the ultraviolet protective factor (UPF) of fabrics coated with TiO2 nanoparticles made using an in-situ synthesis method and more accurately assess the intrinsic properties of the textile. The cotton-polyester twill fabric (70–30%) (246.67 g/m2) was coated in-situ with TiO2 nanoparticles. In-situ coating is conducted in 4 steps; washing the fabrics, preparation of nanoparticles, injecting the nanoparticles into fabrics, and drying the fabric after coating. The scanning electron microscope (SEM) and X-ray diffraction (XRD), FTIR spectrometer, dynamic light scattering (DLS) and UV-Vis spectrophotometer were used to analyse the data of the coating and UPF results. Also, four standards such as ASTM D737, ISIRI 8332, ISIRI 4199, and ISIRI 567 were used for analyzing the intrinsic properties of a textile. The results of SEM, XRD and DLS altogether confirmed the in-situ formation of nanoparticles onto textile fibers. Moreover, the UPF value of the uncoated and coated fabrics was 3.67 and 55.82, respectively. It was shown that the in-situ deposition of TiO2 nanoparticles on fabric can provide adequate protection against UVR. Also, the results of analyzing the intrinsic properties of the textile showed that there were no significant differences in the intrinsic properties between the coated and uncoated fabrics. Based on the results, it can be concluded that the UV protective properties of workwear fabrics can be improved by coating TiO2 nanoparticles on them without any effect on the cooling effect of perspiration evaporation.
- Published
- 2022
- Full Text
- View/download PDF
42. New exact solutions for Davey–Stewartson system
- Author
-
Taghizadeh, N., primary, Neirameh, A., additional, and Shokooh, S., additional
- Published
- 2012
- Full Text
- View/download PDF
43. New Application of Direct Algebraic Method to Eckhaus Equation
- Author
-
Taghizadeh, N., primary, Neirameh, A., additional, and Shokooh, S., additional
- Published
- 2012
- Full Text
- View/download PDF
44. Determination of bismuth and copper using adsorptive stripping voltammetry couple with continuous wavelet transform
- Author
-
Khaloo, Shokooh S., primary, Ensafi, Ali A., additional, and Khayamian, T., additional
- Published
- 2007
- Full Text
- View/download PDF
45. Analysis of electroplating baths by capillary electrophoresis with high voltage contactless conductivity detection
- Author
-
Zhang, Ling, primary, Khaloo, Shokooh S, additional, Kubán, Pavel, additional, and Hauser, Peter C, additional
- Published
- 2006
- Full Text
- View/download PDF
46. Rapid electrophoretic separations in short capillaries using contactless conductivity detection and a sequential injection analysis manifold for hydrodynamic sample loading
- Author
-
Wuersig, Andreas, primary, Kubáň, Pavel, additional, Khaloo, Shokooh S., additional, and Hauser, Peter C., additional
- Published
- 2006
- Full Text
- View/download PDF
47. Automatic generation control system for an industrial facility with onsite generation.
- Author
-
Dai, J.J., Castro, H., Jianjun Guo, Khandelwal, T., Shokooh, S., and Shokooh, F.
- Published
- 2009
- Full Text
- View/download PDF
48. Rapid electrophoretic separations in short capillaries using contactless conductivity detection and a sequential injection analysis manifold for hydrodynamic sample loading.
- Author
-
Andreas Wuersig, Pavel Kubáň, Shokooh S. Khaloo, and Peter C. Hauser
- Published
- 2006
49. Determination of traces molybdenum by catalytic adsorptive stripping voltammetry
- Author
-
Ensafi, Ali A. and Khaloo, Shokooh S.
- Subjects
- *
ELECTROCHEMICAL analysis , *MOLYBDENUM , *SURFACE chemistry , *ANALYSIS of variance - Abstract
Abstract: A reliable and very sensitive procedure for the determination of ultra trace of molybdenum is proposed. Molybdenum was determined by cathodic stripping differential pulse voltammetry based on the adsorption collection of the Mo(VI)–Tiron complex on a hanging mercury drop electrode (HMDE). The variation of peak current with pH, concentration of Tiron and chlorate, plus several instrumental parameters such as accumulation time, accumulation potential and scan rate, were optimized. Under optimized condition, the relationship between the peak current and molybdenum concentration is linear in the range of 0.010–21.0ngml-1. The limit of detection was found to be 0.006ngml-1. The relative standard deviation for 10 replicates determination of 0.6 and 10ngml-1 Mo(VI) is equal to 1.3 and 0.9%, respectively. The method was applied to the determination of molybdenum in river water, tap water, well water, plant foodstuff samples such as cucumber, tomato, carrot, and certified steel reference materials. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
50. Comparing the Effects of Positive Psychotherapy and Self-Review on the Well-Being and Resilience in the students as mothers
- Author
-
M Asadolah Tooyserkani, Mehrangiz Payvastegar, Shokooh sadat Banijamali, and gholamreza dehshiri
- Subjects
Subjective Well-being ,Resilience ,Positive Psychotherapy ,self-review ,mother's students ,Psychology ,BF1-990 - Abstract
The aim of this study was to compare the effectiveness of positive psychotherapy and Self-Review on well-being and resilience among students as mothers. The study sample was consisted of twenty seven students of Alzahra University, who were mothers as well..They were selected through convenience sampling, and were randomly assigned to three self-review, positive psychotherapy and control groups. The data were measured using two questionnaires: Subjective Well-Being Questionnaire (RSPWB-SF) and Resilience Scale for Adults (RSA) in three phases of pretest, posttest and follow up. For the first group experimental,the positive psychotherapy was administered in seven sessions and for the second group, self-reviewtherapy was provided in six sessions. The control group has received no intervention. The data was analyzed by descriptive statistic and multivariate covariance method. The results indicated that mean scores of subjective well-being in post-test and follow-up were significantly increased in self- review and Positive Psychotherapy groups compared to control group. But resilience was not significant. Accordingly, the findings suggested that self-review and positive psychotherapy interventions had a significant effect on increasing the well-being of mothers. However, there was no significant difference between the two methods in terms of effectiveness on subjective well-being. These results can be construed as an evidence for using positive psychotherapy or self-review in psychological well-being for students as mothers.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.